SLU-PP-332 Capsules

Buy SLU-PP-332 Online

SLU-PP-332 is a synthetic estrogen-related receptor (ERR) agonist developed as a research tool for investigating exercise-responsive metabolic pathways. It has attracted attention for its ability to activate molecular programs associated with aerobic exercise in preclinical models.

Product Information

SLU-PP-332 acts primarily through ERR alpha, ERR beta, and ERR gamma, with particularly strong activity at ERR alpha. Animal research has linked the compound to increased mitochondrial function, oxidative muscle fibers, fatty-acid oxidation, and exercise endurance.

How It Works

SLU-PP-332 activates ERR nuclear receptors that regulate genes involved in mitochondrial metabolism, oxidative phosphorylation, and fatty-acid utilization. This can trigger a molecular response resembling aspects of aerobic exercise.

POTENTIAL BENEFITS

1. Exercise-Mimetic Activity

SLU-PP-332 can activate an acute aerobic-exercise gene program in experimental models. This makes it one of the most prominent small molecules currently studied as a pharmacological exercise mimetic.

2. Supports Mitochondrial Function

Cellular and animal research indicates that SLU-PP-332 increases mitochondrial function and cellular respiration, providing a mechanistic basis for its metabolic effects.

3. Enhanced Exercise Endurance

In mice, SLU-PP-332 increased oxidative skeletal-muscle fibers and improved exercise endurance. These findings have driven interest in ERR activation as a strategy for improving muscle metabolic capacity.

4. Metabolic Health Research

Animal models of obesity and metabolic syndrome have shown increased energy expenditure, greater fatty-acid oxidation, reduced fat accumulation, and improved insulin sensitivity following SLU-PP-332 exposure.

Dosage

There is no established human dosage for SLU-PP-332. The compound remains primarily a preclinical research tool, and animal doses should not be interpreted as human dosing recommendations. Recent literature continues to describe it as an emerging exercise mimetic requiring further research.

Side Effects

Human safety data are not established. Potential long-term effects of sustained ERR activation, cardiovascular effects, metabolic disturbances, and interactions with other metabolic agents remain important unanswered questions.

References

1. PubMed - SLU-PP-332 exercise-mimetic research PubMed
2. PubMed - SLU-PP-332 metabolic syndrome research PubMed
3. PubMed - SLU-PP-332 doping-control research PubMed

Note: BehemothLabz does not sell this product. Purchase links on this page may direct you to third-party suppliers through affiliate links.

Please click here to see how purchases actually work on this site.